The fully linked HTML version of this article has now been published.
JCS ePress
online publication date 1 Feb 2005
doi: 10.1242/jcs.01653
Research Article
The Tie-2 ligand Angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism
Marion Scharpfenecker,
Ulrike Fiedler,
Yvonne Reiss,
and
Hellmut G. Augustin*
* Author for correspondence (e-mail: augustin{at}angiogenese.de)
The angiopoietins Ang-1 and Ang-2 have been identified as ligands of the endothelial receptor tyrosine kinase Tie-2, which controls vascular assembly and endothelial quiescence. The largely complementary phenotypes of Ang-1-deficient mice and Ang-2-overexpressing mice have led to an antagonistic model in which Ang-1 acts as Tie-2-activating agonist and Ang-2 acts as a Tie-2-inhibiting antagonist. To date, no mechanistic equivalent of the antagonistic Ang-1/Ang-2 model has been established and the mechanisms of Ang-2 function in particular remain mysterious. We have studied the effector functions of Ang-1 and Ang-2 on quiescent endothelial cells using a three-dimensional co-culture model of endothelial cells and smooth-muscle cells. Endothelial-cell monolayer integrity in this model is dependent on Tie-2 signaling, as evidenced by detaching endothelial cells following exposure to the small molecular weight Tie-2 inhibitor A-422885.66, which cannot be overcome by exogenous Ang-1. Accordingly, exogenous Ang-2 rapidly destabilizes the endothelial layer, which can be observed within 30-60 minutes and leads to prominent endothelial-cell detachment within 4 hours. Exogenous Ang-2-mediated endothelial-cell detachment can be rescued by Ang-1, soluble Tie-2 and vascular endothelial growth factor. Similar findings were obtained in an umbilical-vein explant model. Ang-2 is mainly produced by endothelial cells and therefore acts primarily in an autocrine manner. Thus, stimulated release of endogenous Ang-2 or overexpression of Ang-2 in endothelial cells perturbs co-culture spheroid integrity, which can be rescued by exogenous Ang-1 and vascular endothelial growth factor. However, autocrine Ang-2-mediated endothelial-cell detachment cannot be blocked by soluble Tie-2. Taken together, the data demonstrate for the first time the antagonistic Ang-1/Ang-2 concept in a defined cellular model and identify Ang-2 as a rapidly acting autocrine regulator of the endothelium that acts through an internal autocrine loop mechanism.
This article has been cited by other articles:
|
|
|
|
 
T. Kohno, T. Daa, H. Otani, I. Shimokawa, S. Yokoyama, and T. Matsuyama
Aberrant expression of BAFF receptor, a member of the tumor necrosis factor receptor family, in malignant cells of nonhematopoietic origins
Genes Cells,
October 1, 2008;
13(10):
1061 - 1073.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M van der Heijden, G P van Nieuw Amerongen, P Koolwijk, V W M van Hinsbergh, and A B J Groeneveld
Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ARDS in septic and non-septic critically ill patients
Thorax,
October 1, 2008;
63(10):
903 - 909.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Kumpers, C. Koenecke, H. Hecker, J. Hellpap, R. Horn, W. Verhagen, S. Buchholz, B. Hertenstein, J. Krauter, M. Eder, et al.
Angiopoietin-2 predicts disease-free survival after allogeneic stem cell transplantation in patients with high-risk myeloid malignancies
Blood,
September 1, 2008;
112(5):
2139 - 2148.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Anargyrou, E. Terpos, T. P. Vassilakopoulos, A. Pouli, S. Sachanas, T. Tzenou, S. Masouridis, D. Christoulas, M. K. Angelopoulou, E. M. Dimitriadou, et al.
Normalization of the serum angiopoietin-1 to angiopoietin-2 ratio reflects response in refractory/resistant multiple myeloma patients treated with bortezomib
Haematologica,
March 1, 2008;
93(3):
451 - 454.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Lan, B. Liu, H. Yao, F. Li, T. Weng, G. Yang, W. Li, X. Cheng, N. Mao, and X. Yang
Essential Role of Endothelial Smad4 in Vascular Remodeling and Integrity
Mol. Cell. Biol.,
November 1, 2007;
27(21):
7683 - 7692.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Liu, J. Wang, B. Kinzel, M. Mueller, X. Mao, R. Valdez, Y. Liu, and E. Li
Dosage-dependent requirement of BMP type II receptor for maintenance of vascular integrity
Blood,
September 1, 2007;
110(5):
1502 - 1510.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. P. de Caestecker
Angiopoietin-2 and Glomerular Proteinuria
J. Am. Soc. Nephrol.,
August 1, 2007;
18(8):
2217 - 2218.
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Dome, M. J.C. Hendrix, S. Paku, J. Tovari, and J. Timar
Alternative Vascularization Mechanisms in Cancer: Pathology and Therapeutic Implications
Am. J. Pathol.,
January 1, 2007;
170(1):
1 - 15.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Daly, E. Pasnikowski, E. Burova, V. Wong, T. H. Aldrich, J. Griffiths, E. Ioffe, T. J. Daly, J. P. Fandl, N. Papadopoulos, et al.
Angiopoietin-2 functions as an autocrine protective factor in stressed endothelial cells
PNAS,
October 17, 2006;
103(42):
15491 - 15496.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Pfaff, U. Fiedler, and H. G. Augustin
Emerging roles of the Angiopoietin-Tie and the ephrin-Eph systems as regulators of cell trafficking
J. Leukoc. Biol.,
October 1, 2006;
80(4):
719 - 726.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Kalomenidis, A. Kollintza, I. Sigala, A. Papapetropoulos, S. Papiris, R. W. Light, and C. Roussos
Angiopoietin-2 Levels Are Elevated in Exudative Pleural Effusions
Chest,
May 1, 2006;
129(5):
1259 - 1266.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. P.J. Brindle, P. Saharinen, and K. Alitalo
Signaling and Functions of Angiopoietin-1 in Vascular Protection
Circ. Res.,
April 28, 2006;
98(8):
1014 - 1023.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. D. Phelps, D. L. Updike, E. C. Bullen, P. Grammas, and E. W. Howard
Transcriptional and posttranscriptional regulation of angiopoietin-2 expression mediated by IGF and PDGF in vascular smooth muscle cells
Am J Physiol Cell Physiol,
February 1, 2006;
290(2):
C352 - C361.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. E. Fathers, C. M. Stone, K. Minhas, J. J.A. Marriott, J. D. Greenwood, D. J. Dumont, and B. L. Coomber
Heterogeneity of Tie2 Expression in Tumor Microcirculation: Influence of Cancer Type, Implantation Site, and Response to Therapy
Am. J. Pathol.,
December 1, 2005;
167(6):
1753 - 1762.
[Abstract]
[Full Text]
[PDF]
|
|
|
© The Company of Biologists Ltd 2005
